Pancreatic cancer cells express interleukin-13 and -4 receptors, and their growth is inhibited by pseudomonas exotoxin coupled to interleukin-13 and -4

Anticancer Research

Volumn 19, Issue 1 A, 1999, Pages 125-131

  Kornmann, Marko ^a   Kleeff, JÖrg ^a   Debinski, Waldemar ^b   Korc, Murray ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Human pancreatic cancer; IL 4 13 pseudomonas exotoxin chimeric protein; Interleukin 4 13

Indexed keywords

CHIMERIC PROTEIN; INTERLEUKIN 13; INTERLEUKIN 13 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; PSEUDOMONAS EXOTOXIN; RECOMBINANT INTERLEUKIN 13; RECOMBINANT INTERLEUKIN 4;

ARTICLE; CANCER CELL; CANCER INHIBITION; CELL GROWTH; CONTROLLED STUDY; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; NORTHERN BLOTTING; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADP RIBOSE TRANSFERASES; BACTERIAL TOXINS; CELL DIVISION; EXOTOXINS; HUMANS; INTERLEUKIN-13; INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT; INTERLEUKIN-4; PANCREATIC NEOPLASMS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-13; RECEPTORS, INTERLEUKIN-4; RECOMBINANT FUSION PROTEINS; TUMOR CELLS, CULTURED; VIRULENCE FACTORS;

EID: 0032897715     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Zurawski G and De Vries JE: Interleukin 13 elicits a subset of the activities of its close relative interleukin 4. Stem Cells 12: 169-174, 1994.
2. Ihle JN :Cytokine receptor signalling. Adv Cancer Res 68: 3-65, 1996.
3. Idzerda RI, March CJ, Mosley B, Lyman SD, Vanden Bos T, Gimpel SD, Din WS, Grabstein KH, Widmer MB, Park LS, Cosman D and Beckmann MP :Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily. J Exp Med 171: 861-873, 1990.
4. Keegan AD and Pierce JH: The interleukin-4 receptor: signal transduction by a hematopoietin receptor. J Leukoc Biol 55: 272-279, 1994.
5. Obiri NI, Debinski W, Leonard WJ and Puri RK: Receptor for interleukin-13. J Biol Chem 270: 8797-8804, 1995.
6. Obiri NI, Leland P, Murata T, Debinski W and Puri RK: The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor. J Immunol 158: 756-764, 1997.
7. Caput D, Laurent P, Kaghad M, Lelias J-M, Lefort S, Vita N and Ferrara P: Cloning and characterization of a specific interleukin (IL)-13 bindillg protein structurally related to the IL-5 receptor α chain. J Biol Chem 271: 16921-16926, 1996.
8. Debinski W Miner R, Leland P, Obiri NI and Puri RK: Receptor for interleukin (IL) 13 does not interact with IL4 but receptor for IL4 interacts with ÍL13 on human glioma cells. J Biol Chem 271: 22428-22433, 1996.
9. Aman MJ, Tayebi N, Obiri NI, Puri RK, Modi WS and Leonard WJ: cDNA cloning and characterization of the human interleukin 13 receptor α chain. J Biol Chem 271: 29265-29270, 1996.
10. Miloux B, Laurent P, Bonnin O, Lupker J, Caput D, Vita N and Ferrara P: Cloning of the human IL-13Rα1 chain and reconstitution with the IL-4Rα of a functional IL-4/IL-13 receptor complex. FEBS Lett 401: 163-166, 1997.
11. Murata T, Obiri NI, Debinski W and Puri RK: Structure of the IL-13 receptor: Analysis of subunit composition in cancer and immune cells. Biochem Biophys Res Commun 238: 90-94, 1997.
12. Debinski W, Puri RK, Kreitman RJ and Pastan I: A wide range of human cancers express interleukin 4 (IL4) receptors that can be targeted with chimeric toxin composed of IL4 and Pseudomonas exotoxin. J Biol Chem 268: 14065-14070, 1993.
13. Obiri NI, Hillman G, Haas GP, Sud S and Puri RK: Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4. J Clin Invest 91: 88-93, 1993.
14. Puri RK, Debinski W, Obiri N, Kreitman R and Pastan I. Human renal cell carcinoma cells are sensitive to the cytotoxic effect of a chimeric protein composed of human interleukin-4 and Pseudomonas exotoxin. Cellular Immunol 154: 369-379, 1994.
15. Puri RK, Leland P, Obiri NI, Husain SR, Kreitman RJ, Haas GP, Pastan I and Debinski W: Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR). Blood 87: 4333-4339, 1996.
16. Debinski W, Obiri NI, Pastan I and Puri RK: A novel chimeric protein composed of interleukin 13 and Pseudomonas exotoxin is highly cytotoxic to human carcinoma cells expressing receptors for interleukin 13 and interleukin 4. J Biol Chem 270: 16775-16780, 1995.
17. Debinski W. Pur RK and Pastan I: Interleukin-4 receptors expressed on tumor cells may serve as a target for anticancer therapy using chimeric Pseudomonas exotoxin. Int J Cancer 58: 744-748, 1994.
18. Pastan I, Chaudahry VK and FitzGerald DJ: Recombinant toxins as novel therapeutic agents. Annu Rev Biochem 61: 331-354, 1992.
19. Debinski W and Pastan I: An immunotoxin with increased activity and homogeneity produced by reducing the number of lysine residues in recombinant Pseudomonas exotoxin. Bioconjugate Chem 5: 40-46, 1994.
20. Link KH, Gansauge F, Pillasch J and Beger HG: Multimodal therapies of in pancreatic cancer. The future. Int J Pancreatol 21: 71-83, 1997.
21. Baldwin RL, Kobrin MS, Tran T, Pastan I and Korc M: Cytotoxic effects of TGF-α-Pseudomonas exotoxin A fusion protein in human pancreatic carcinoma cells. Pancreas 13: 16-21, 1996.
22. Kornmann M, Ishiwata T, Beger HG and Korc M: Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions. Oncogene 15: 1417-1424, 1997.
23. Kornmann M. Arber N, and Korc M: Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum. J Clin Invest 101: 344-352, 1998.
24. Baldwin RL and Korc M: Growth inhibition of human pancreatic carcinoma cells by transforming growth factor beta-1. Growth factors 8: 23-34, 1993.
25. Raitano AB and Korc M: Tumor necrosis factor up-regulates γ-interferon binding in a human carcinoma cell line. J Biol Chem 265: 10466-10472, 1990.
26. Bergmann U, Funatomi H, Yokoyama M, Beger HG and Korc M: Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res 55: 2007-2011, 1995.
27. Gauchat J-F, Schlagenhauf E, Feng N-P, Moser R, Yamage M, Jeannin P, Alouani S, Elson G, Notarangelo LD, Wells T, Eugster H-P and Bonnefoy J-Y: A novel 4-kb interleukin-13 receptor a mRNA expressed in human B, T, and endothelial cells encoding an alternative type-II interleukin-4 interleukin-13 receptor. Eur J Immunol 27: 971-978, 1947.
28. Lin J-X, Migone TS, Tsang M, Friedmann M, Weatherbee JA, Li Z, Yamauchi A, Bloom E, Mietz J, John S and Leonard WJ: The role of shared receptor motifs and common stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2: 331-334, 1995.
29. Topp MS, Papadimitriou CA, Eitelbach F, Oelmann E, Koehler B, Oberberg D, Von Marshall Z, Reufi B, Stein H, Thiel E and Berdel WE: Antiproliferative effect of human interleukin-4 in human cancer cell lines: studies on the mechanism. Leuk Lymphoma 19: 319-328, 1995.
30. Serve H, Oelmann E, Herweg A, Oberberg D, Serve S, Reufi M, Muecke C, Minty A, Thiel E and Berdel WE: Inhibition of proliferation and clonal growth of human breast cancer cells by interleukin 13. Cancer Res 56: 3583-3588, 1996.
31. Blais Y, Gingras S, Haagensen DE, Labrie F and Simard J: Interleukin-4 and interleukin-13 inhibit estrogen-induced breast cancer cell proliferation and stimulate GCDFP-15 expression in human breast cancer cells. Mol Cell Endocrinol 121: 11-18, 1996.
32. Maini A, Hillman G, Haas GP, Wang CY, Montecillo E, Hamzavi F, Pontes JE, Leland P, Pastan I, Debinski W and PURI RK: Interleukin-13 receptors on human prostate carcinoma cell lines represent a novel target for a chimeric protein composed of IL-13 and a mutated form of Pseudomonas exotoxin. J Urol 158: 948-953, 1997.
33. Beger HG, Buchler MW and Schoenberg MH: Cancer of the pancreas, Universitatsverlag Ulm, Ulm, Germany, 1996.